Nisuki Bio-Product Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 22-06-2024
- Paid Up Capital ₹ 2.50 M
as on 22-06-2024
- Company Age 23 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 9.00 M
as on 22-06-2024
About Nisuki Bio-Product
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company has closed loans amounting to ₹9.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Smita Parekh and Kiran Parekh serve as directors at the Company.
- CIN/LLPIN
U24100GJ2001PTC039507
- Company No.
039507
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationNa, Gujarat
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Nisuki Bio-Product Private Limited offer?
Nisuki Bio-Product Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Herbal Capsules.
Who are the key members and board of directors at Nisuki Bio-Product?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Smita Parekh  | Director | 28-Aug-2017 | Current |
| Kiran Parekh | Director | 09-May-2001 | Current |
Financial Performance of Nisuki Bio-Product.
Nisuki Bio-Product Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nisuki Bio-Product?
In 2017, Nisuki Bio-Product had a promoter holding of 87.60% and a public holding of 12.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nisuki Multitronix Private LimitedActive 23 years 7 monthsSmita Parekh and Kiran Parekh are mutual person
- Nisuki Marketing Private LimitedActive 33 years 9 months
Smita Parekh and Kiran Parekh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Surat People's Co-Op Bank Ltd Creation Date: 20 Nov 2009 | ₹9.00 M | Satisfied |
How Many Employees Work at Nisuki Bio-Product?
Unlock and access historical data on people associated with Nisuki Bio-Product, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nisuki Bio-Product, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nisuki Bio-Product's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
